These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 36949513

  • 1. The role of proteasome in muscle wasting of experimental arthritis.
    Teixeira VON, Bartikoski BJ, do Espirito Santo RC, Alabarse PVG, Ghannan K, Silva JMS, Filippin LI, Visioli F, Martinez-Gamboa L, Feist E, Xavier RM.
    Adv Rheumatol; 2023 Mar 22; 63(1):14. PubMed ID: 36949513
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis.
    Pope JE, Haraoui B, Thorne JC, Vieira A, Poulin-Costello M, Keystone EC.
    Ann Rheum Dis; 2014 Dec 22; 73(12):2144-51. PubMed ID: 23979914
    [Abstract] [Full Text] [Related]

  • 4. Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study.
    Gaubitz M, Göttl KH, Behmer O, Lippe R, Meng T, Löschmann PA.
    Clin Rheumatol; 2017 Sep 22; 36(9):1989-1996. PubMed ID: 28756532
    [Abstract] [Full Text] [Related]

  • 5. A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial.
    Nam JL, Villeneuve E, Hensor EM, Wakefield RJ, Conaghan PG, Green MJ, Gough A, Quinn M, Reece R, Cox SR, Buch MH, van der Heijde DM, Emery P.
    Ann Rheum Dis; 2014 Jun 22; 73(6):1027-36. PubMed ID: 24618266
    [Abstract] [Full Text] [Related]

  • 6. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 22; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 7. The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis.
    Wiland P, Dudler J, Veale D, Tahir H, Pedersen R, Bukowski J, Vlahos B, Williams T, Gaylord S, Kotak S.
    J Rheumatol; 2016 Jul 22; 43(7):1268-77. PubMed ID: 27252426
    [Abstract] [Full Text] [Related]

  • 8. When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET).
    Dougados MR, van der Heijde DM, Brault Y, Koenig AS, Logeart IS.
    J Rheumatol; 2014 Oct 22; 41(10):1922-34. PubMed ID: 25128520
    [Abstract] [Full Text] [Related]

  • 9. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.
    Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Takeuchi T, Japan Biological Agent Study Integrated Consortium.
    Mod Rheumatol; 2010 Dec 22; 20(6):531-8. PubMed ID: 20574649
    [Abstract] [Full Text] [Related]

  • 10. Safety and effectiveness of 6 months' etanercept monotherapy and combination therapy in Japanese patients with rheumatoid arthritis: effect of concomitant disease-modifying antirheumatic drugs.
    Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Hirose T, Yoshinaga T, Suzukawa M.
    J Rheumatol; 2013 Oct 22; 40(10):1658-68. PubMed ID: 23908446
    [Abstract] [Full Text] [Related]

  • 11. Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis.
    Khraishi M, Millson B, Woolcott J, Jones H, Marshall L, Ruperto N.
    Pediatr Rheumatol Online J; 2019 Sep 10; 17(1):64. PubMed ID: 31500631
    [Abstract] [Full Text] [Related]

  • 12. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA, Guzman RM, Xavier RM, Simon JA, Mele L, Pedersen R, Ferdousi T, Koenig AS, Kotak S, Vlahos B.
    J Clin Rheumatol; 2014 Jan 10; 20(1):25-33. PubMed ID: 24356474
    [Abstract] [Full Text] [Related]

  • 13. The effect of TNF-α inhibitor treatment on microRNAs and endothelial function in collagen induced arthritis.
    Gunter S, Michel FS, Fourie SS, Singh M, le Roux R, Manilall A, Mokotedi LP, Millen AME.
    PLoS One; 2022 Jan 10; 17(2):e0264558. PubMed ID: 35213638
    [Abstract] [Full Text] [Related]

  • 14. Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis.
    Bae SC, Gun SC, Mok CC, Khandker R, Nab HW, Koenig AS, Vlahos B, Pedersen R, Singh A.
    BMC Musculoskelet Disord; 2013 Jan 08; 14():13. PubMed ID: 23294908
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Radiographic and clinical outcomes following etanercept monotherapy in Japanese methotrexate-naïve patients with active rheumatoid arthritis.
    Takeuchi T, Miyasaka N, Pedersen R, Sugiyama N, Hirose T.
    Mod Rheumatol; 2020 Mar 08; 30(2):259-268. PubMed ID: 30836801
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial.
    Kim HY, Hsu PN, Barba M, Sulaiman W, Robertson D, Vlahos B, Khandker R, Nab H, Freundlich B, Koenig A.
    Int J Rheum Dis; 2012 Apr 08; 15(2):188-96. PubMed ID: 22462423
    [Abstract] [Full Text] [Related]

  • 20. Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis.
    van Vollenhoven RF, Østergaard M, Leirisalo-Repo M, Uhlig T, Jansson M, Larsson E, Brock F, Franck-Larsson K.
    Ann Rheum Dis; 2016 Jan 08; 75(1):52-8. PubMed ID: 25873634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.